Examples
Worked examples
- Is an instance
An IRB reviewing a Phase 1 oncology trial's consent form flags language implying that dose-escalation decisions are made to optimize each patient's individual treatment, when they are in fact set by a fixed dose-escalation protocol designed to characterize toxicity across the study cohort -- exactly the therapeutic misconception the consent process needs to correct before enrollment.
- Is an instance
A CITI Human Subjects Research training module cites therapeutic misconception, alongside undue influence and coercion, as one of the specific threats to voluntary, informed consent that consent-form language and the consent conversation itself -- not just the written document -- are responsible for addressing, particularly in early-phase and psychiatric research where participants may be especially likely to conflate research procedures with personalized care.
Counter-examples
Looks similar, but isn't
- Not an instance
A participant who accurately understands they are in a randomized trial and are being assigned to a study arm by chance, but who overestimates how effective the experimental drug is likely to be, is exhibiting therapeutic misestimation, not therapeutic misconception -- they have the structure of the research correctly, just not the specific risk-benefit calculation.
- Not an instance
A terminally ill patient enrolling in a trial while realistically understanding it may not help them, but hoping it will, is displaying therapeutic optimism -- a generally acceptable, even expected, state of mind that should not be treated as a consent defect requiring correction the way therapeutic misconception is.
Editorial commentary
Therapeutic misconception is the failure of a research participant to understand that a clinical study’s procedures and assignments are driven by a fixed research protocol answering a generalizable scientific question, rather than by an individualized clinical judgment about what is best for them personally. It is a recognized threat to the validity of informed consent in human-subjects research, and it is distinct from two related but ethically less concerning states: therapeutic misestimation and therapeutic optimism.
Origin of the term
Psychiatrist and bioethicist Paul S. Appelbaum, together with Loren H. Roth and Charles W. Lidz, first described the phenomenon in a 1982 article in the International Journal of Law and Psychiatry, based on their empirical work interviewing psychiatric research participants. The concept reached a much wider bioethics and research-administration audience in 1987, when Appelbaum, Roth, Lidz, and colleagues published ‘False Hopes and Best Data: Consent to Research and the Therapeutic Misconception’ in the Hastings Center Report, defining the misconception as the denial that participation in clinical research can carry disadvantages that stem from the nature of the research process itself, independent of any individual treatment decision.
Why the distinction matters for consent
A research protocol — randomization, fixed dosing schedules, placebo arms, mandated procedures unrelated to a participant’s own condition — exists to produce valid, generalizable answers across a study population, and by design it is not optimized for any one participant the way a treating clinician’s judgment would be. A participant operating under therapeutic misconception believes the opposite: that each procedure and assignment was selected because it is what is best for them individually. That belief matters because U.S. federal regulations require that consent be based on an accurate understanding of what a study actually involves — a person who believes a randomized placebo-controlled trial is functionally personalized treatment has not received the disclosure the regulations require them to meaningfully understand, even if they signed a consent form that technically stated otherwise.
Distinguishing misconception, misestimation, and optimism
Bioethics literature separates therapeutic misconception from two related states that are not treated as consent defects in the same way. Therapeutic misestimation describes a participant who correctly understands the structural distinction between research and treatment but still miscalculates the specific probability of benefit or harm — an error of degree, not of kind. Therapeutic optimism describes a participant who accurately understands both the research structure and its realistic risk-benefit profile, yet reasonably hopes for a favorable personal outcome anyway — a psychologically normal and generally ethically unproblematic stance, since it does not reflect a misunderstanding of what the study is. Only therapeutic misconception itself — the conflation of research procedure with individualized care — is treated in the literature as undermining the validity of consent.
Where it shows up in research administration
Therapeutic misconception is discussed most often in connection with early-phase clinical trials, where the gap between a study’s actual purpose (establishing safety and dosing) and a participant’s hoped-for outcome (a cure) is widest, and in psychiatric and other vulnerable-population research, the setting in which Appelbaum, Roth, and Lidz first documented it. IRB-facing guidance and consent-form review commonly recommend explicit language distinguishing the study’s research purpose from clinical care, disclosure that a participant’s physician and the study’s investigator may have different obligations even when they are the same person, and, where relevant, explicit acknowledgment that randomization or a placebo arm means some participants will not receive an active intervention — all aimed at the specific misunderstanding therapeutic misconception describes, rather than at consent form completeness generally.
References
- Appelbaum, Paul S., Loren H. Roth, and Charles W. Lidz, “The Therapeutic Misconception: Informed Consent in Psychiatric Research,” International Journal of Law and Psychiatry 5, nos. 3-4 (1982): 319-329.
- Appelbaum, Paul S., Loren H. Roth, Charles W. Lidz, Paul Benson, and William Winslade, “False Hopes and Best Data: Consent to Research and the Therapeutic Misconception,” Hastings Center Report 17, no. 2 (1987): 20-24.
- Appelbaum, Paul S., “Therapeutic Misconception in Research Subjects,” Journal of Medical Ethics, 2012.
Machine-readable encodings
Use in your systems
<role vocab="credit"
vocab-identifier="https://casrai.org/dictionary/"
vocab-term="Therapeutic Misconception"
vocab-term-identifier="https://casrai.org/dictionary/term/therapeutic-misconception" />{
"@context": "https://schema.org",
"@type": "DefinedTerm",
"@id": "https://casrai.org/dictionary/term/therapeutic-misconception",
"name": "Therapeutic Misconception",
"identifier": "https://casrai.org/dictionary/term/therapeutic-misconception",
"description": "Therapeutic misconception is the failure of a research participant to understand that the procedures, interventions, and decisions in a clinical study are driven by a fixed research protocol designed to answer a generalizable scientific question -- not by an individualized clinical judgment about what is best for that particular participant -- leading the participant to believe study assignment and procedures were chosen for their personal medical benefit in the same way a treating physician's recommendations would be. The term was coined by Paul S. Appelbaum, Loren H. Roth, and Charles W. Lidz in a 1982 article in the International Journal of Law and Psychiatry, and introduced more widely to the bioethics community in a 1987 Hastings Center Report article, 'False Hopes and Best Data: Consent to Research and the Therapeutic Misconception.' It is distinguished from therapeutic misestimation, in which a participant correctly understands that they are in a research study but still over- or under-estimates its specific risks and benefits, and from therapeutic optimism, in which a participant realistically understands the research process yet reasonably hopes for a good outcome -- only the first of the three is considered to compromise the validity of informed consent, since it involves a fundamental misunderstanding of what the study is rather than a miscalculation within an accurate understanding of it.",
"inDefinedTermSet": "https://casrai.org/dictionary/domain/compliance-regulatory#set",
"url": "https://casrai.org/dictionary/term/therapeutic-misconception",
"sameAs": [],
"license": "https://creativecommons.org/licenses/by/4.0/",
"publisher": {
"@id": "https://casrai.org/#organization"
},
"author": {
"@id": "https://casrai.org/#editorial-team"
},
"datePublished": "2026-09-01T00:27:57",
"dateModified": "2026-09-01T00:27:57",
"inLanguage": "en-GB",
"isAccessibleForFree": true
}
